Sandeep Sahay

Dr Sahay is a dedicated pulmonary critical care physician with specialization in pulmonary vascular diseases. He is an associate professor affiliated to Weill Cornell Medicine College, Houston Methodist Hospital. He is director of the pulmonary hypertension program at the Houston Methodist Hospital. He is well known for his work in the field of pulmonary hypertension. With a passion for improving patient outcomes, he focuses his research on risk stratification in pulmonary hypertension, PH ILD and chronic thromboembolic pulmonary hypertension. As a national leader in the space, he serves as Principal investigator on multiple phase 2 and 3 clinical trials investigating newer therapies for the treatment of pulmonary arterial hypertension.  Attributed to his sharp knowledge and skill, he is invited to participate in many   scientific steering committees, national leadership roles, guideline panels and in decision making roles with industry and regulatory leadership. He is currently chair of the American college of chest physicians’ Pulmonary Vascular Diseases section. He was awarded ACCP CHEST PAH research grant in 2017 to assess the role of estrogen in portopulmonary hypertension. He is currently chairing two guideline/consensus statement task forces with ISHLT and European Respiratory Society. He also serves executive committee of the American Thoracic Society’s pulmonary circulation assembly and Pulmonary Hypertension association’s scientific leadership committee. He has published numerous scientific papers related to pulmonary hypertension. He is associate editor for pulmonary circulation, JHLT Open and Respiratory Medicine Journals. He serves on end point adjudication committees, DSMB’s for NIH funded studies and multiple clinical trials. He enjoys teaching and learning from the Methodist faculty and fellows as well as medical colleagues around the world. Taking care of PH patients is the most gratifying experience for him. He has demonstrated his passion in improving lives of patients with advanced lung diseases like PH and ILD.